Congress Wealth Management LLC DE Takes $338,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Congress Wealth Management LLC DE acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,000 shares of the company’s stock, valued at approximately $338,000.

Several other large investors have also recently bought and sold shares of TEM. Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI during the fourth quarter worth about $34,000. First Horizon Advisors Inc. increased its position in shares of Tempus AI by 207.9% during the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company’s stock worth $55,000 after acquiring an additional 1,108 shares in the last quarter. FNY Investment Advisers LLC acquired a new stake in shares of Tempus AI during the fourth quarter worth $67,000. IFP Advisors Inc bought a new stake in Tempus AI in the 4th quarter valued at $76,000. Finally, US Bancorp DE acquired a new position in Tempus AI in the 4th quarter worth $80,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Performance

Tempus AI stock opened at $47.83 on Friday. The stock has a 50-day simple moving average of $58.38 and a 200 day simple moving average of $51.52. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45.

Insider Activity

In other news, CEO Eric P. Lefkofsky sold 3,240,234 shares of the firm’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the completion of the sale, the chief executive officer now owns 4,895,589 shares in the company, valued at approximately $287,615,853.75. This trade represents a 39.83 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the company’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $60.00, for a total transaction of $826,200.00. Following the completion of the transaction, the chief accounting officer now owns 57,237 shares in the company, valued at approximately $3,434,220. This trade represents a 19.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,598,969 shares of company stock valued at $317,194,162 over the last three months.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Piper Sandler cut their price target on Tempus AI from $70.00 to $55.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Loop Capital reduced their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. TD Cowen reiterated a “buy” rating and issued a $74.00 price objective (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. William Blair restated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.